Gemcitabine Plus Platinum versus Docetaxel Plus Platinum as First-Line Therapy for Metastatic Nasopharyngeal Carcinoma: A Randomized Clinical Study

BACKGROUND: A well-established first-line chemotherapy standard for metastatic nasopharyngeal carcinoma is yet lacking. OBJECTIVES: To compare the efficacy and safety of gemcitabine plus platinum versus docetaxel plus platinum regimen as first-line therapies for distal metastatic nasopharyngeal carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hui, Lu, Ying, Xu, Zhuohua, Wei, Mingjing, Huang, Haixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152382/
https://www.ncbi.nlm.nih.gov/pubmed/34084103
http://dx.doi.org/10.4103/sjmms.sjmms_471_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152382/
https://www.ncbi.nlm.nih.gov/pubmed/34084103
http://dx.doi.org/10.4103/sjmms.sjmms_471_20

Ejemplares similares